PubMed Health⌕ Search

PubMed · 9915119

AChemS: the beginning. Association for Chemoreception Sciences.

Abstract

This paper unfolds the events, the people and the times that led up to the founding of AChemS and fashioned its character during its early formative years. It describes the path over which AChemS came, going from the original assertions and denials for the need of such an organization to its later inception and nascent development. This narration highlights such topics as the debate over the need for AChemS, the role of National Science Foundation in the founding of AChemS, the derivation of the Association's name, the choice of Sarasota and the Hyatt House as the meeting site, the generation of the programs for the early annual meetings, the adoption of the bylaws, the process of incorporation and tax deferment, and the birth of the Givaudan Lectureship. Most emphatically highlighted, however, is the enthusiasm, commitment and hard work that the members of the chemosensory research community displayed in bringing AChemS to fruition.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M M Mozell. 1998. AChemS: the beginning. Association for Chemoreception Sciences.. https://doi.org/10.1093/chemse%2F23.6.721

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "M2 eCTD: Electronic Common Technical Document Specification." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance defines the means for industry-to-agency transfer of regulatory information that will facilitate the creation, review, life cycle management, and archiving of the electronic submission. The guidance is intended to assist industry in transferring electronically their marketing applications for human drug and biological products to a regulatory authority.

Congresses as Topic↗